Hypothesis 3: The mean difference between “Class 1” (a school attack happens within <i>k</i> kms. of a given school) and “Class 0” (no school attack happens within <i>k</i> kms. of... حسب Lirika Sola (21560710)

Networks favouring more connected individuals results in a significant decrease to the likelihood of network recovery. حسب Adam Lee Miles (14123916)

Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. حسب Aroon La-up (14095691)

الموضوعات:

Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. حسب Courtney A. Swain (15170264)

Baseline patient characteristics. حسب Oscar F. C. van den Bosch (22184246)

الموضوعات:

Effects of s-ketamine and midazolam on respiratory parameters. حسب Oscar F. C. van den Bosch (22184246)

الموضوعات:

Flow chart of the study participants. حسب Oscar F. C. van den Bosch (22184246)

الموضوعات:

Linear regression. حسب Myriam Aïche (22290591)

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. حسب Jelena Filimonovic (22305307)

Logistic regression for influenza results predictors. حسب Reem Eid (20889732)

Survival curve of ART Treatment outcomes. حسب Ekerette Emmanuel Udoh (7326194)

الموضوعات:

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. حسب Haiyang Dong (4783608)

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Logistic regression analysis to predict the efficacy for liver function. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison in baseline variables between efficacy group and non-efficacy group. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Clinical characteristics at baseline and at the end of the study. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Significant condition. حسب Junxia Zhou (14381598)

"…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …"

Structure of a trial. حسب Marcel F. Hinss (14675457)

الموضوعات:

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. حسب Gillian P. McHugo (8965919)